how glp 1 medications are changing consumer behavior Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society 5 years ahead: How GLP-1

GLP-1 (glucagon-like peptide-1 receptor agonists) are prescription medications that mimic a naturally occurring hormone regulating blood sugar and appetite

For patients who have previously been on semaglutide programs and are looking to optimize their results, transitioning to tirzepatide under medical supervision may produce significantly improved outcomes

Medical Contraindications These include a personal or family history of medullary thyroid carcinoma, a diagnosis of Multiple Endocrine Neoplasia syndrome type 2, or known hypersensitivity to semaglutide or other medication components

Matikainen, N

doi: 10.1016/j.cgh.2024.02.022, 25

Our findings in the ZSF1 obese rat model provide novel mechanistic insight that aligns with these clinical data